David J. Wambeke insider trades

Open-market stock purchases and sales by David J. Wambeke, Chief Business Officer at NEUROONE MEDICAL TECHNOLOGIES Corp, from SEC Form 4 filings since Apr 10, 2023.

Track record: 75% of 4 scored buys are up 5% or more since purchase, averaging +89%.

Recent trades

DateStockTradeValue
Aug 28, 2026NMTC NEUROONE MEDICAL TECHNOLOGIES CorpBought (not open market)—
Aug 27, 2026NMTC NEUROONE MEDICAL TECHNOLOGIES CorpBought$67K
Mar 1, 2026NMTC NEUROONE MEDICAL TECHNOLOGIES CorpBought$670K
Mar 1, 2026NMTC NEUROONE MEDICAL TECHNOLOGIES CorpBought (not open market)—

Companies traded

  • NMTC NEUROONE MEDICAL TECHNOLOGIES Corp: 2 buys, last Aug 28, 2026
  • DMAC DiaMedica Therapeutics Inc: 3 buys, last Jun 1, 2025

Get free alerts when David J. Wambeke files a new trade →